Strength Training Effective for Managing Blood Pressure, Study Finds

Translate to Spanish or other 102 languages!

Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes
Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure or hypertension is a common condition that can lead to serious problems without proper management. 
  • High blood pressure management can involve using medications and lifestyle modifications. 
  • Data from a systematic review and meta-analysis found that strength training may be an effective non-medication option for the management of high blood pressure. However, its effectiveness depends on factors like intensity level and duration.

Follow the link below to read the full story on Medical News Today: https://www.medicalnewstoday.com/articles/hypertension-strength-training-helps-manage-high-blood-pressure?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -